Science Advances (journal) Archive — Page 1 of 2
-
November 3, 2022
Study explores possible drug target for neurological problems
A team at Case Western Reserve University and Vanderbilt University Medical Center has determined with atomic-level precision how two established drugs bind to and alter the conformation of a cell membrane transporter protein called NKCC1, shutting down its activity. -
October 20, 2022
Aging beta cells hasten Type 2 diabetes
Vanderbilt investigators have found that aging induces chronic cellular stress in pancreatic beta cells, which could contribute to the development of diabetes as we age. -
December 16, 2021
Game theory points to new DNA data privacy solutions
Vanderbilt research is blazing a trail for the application of game theory to genomic and health data reidentification risk. -
September 10, 2021
Caught in a web: study reveals that immune cells cooperate to trap and kill bacteria
Vanderbilt researchers have identified a new antibacterial mechanism that could inspire novel strategies for combating staph and other extracellular bacterial pathogens. -
July 8, 2020
New clues to lung-scarring disease may aid treatment
Scientists at Vanderbilt University Medical Center and the Translational Genomics Research Institute (TGen) in Phoenix, Arizona, have discovered previously unreported genetic and cellular changes that occur in the lungs of people with pulmonary fibrosis (PF). -
December 4, 2019
Genetic screen in worms reveals critical step in insulin synthesis
The identification of a protein important for insulin synthesis may hold clues for understanding the pathogenesis of diabetes. -
August 23, 2018
Clue to treating obesity found in body’s ‘rheostat’
Researchers at Vanderbilt University and the University of Michigan have discovered a critical factor in the rheostatic control of body weight by the brain.